A method and devices for stimulating visceral pelvic or somatic nerves or their pathways of a female person suffering from a pelvic condition of nerve dysfunction in which non-electrical, external physical stimulation is applied to the clitoral region of the person.

Methods may be provided to identify a medical implant from a plurality of medical implants to be fixed to an anatomical surface. Dimensional parameters for each of the plurality of medical implants may be provided, and dimensional parameters corresponding to the anatomical surface may be provided. The dimensional parameters for each of the plurality of medical implants may be compared with the dimensional parameters corresponding to the anatomical surface, and one of the medical implants may be selected from the plurality of medical implants based on comparing the dimensional parameters for each of the plurality of medical implants with the dimensional parameters corresponding to the anatomical surface. An identification of the medical implant selected from the plurality of medical implants may be provided through a user interface. Related devices and computer program products are also discussed.

An intravaginal pessary device in an applicator is provided. The device has a top and a bottom, and a sidewall that extends between the top and the bottom. The sidewall, top and bottom form an outer periphery defining a total area of the device. The pessary device has a maximum diameter that is less than about 25 mm. The pessary device and applicator exhibit a maximum expulsion force that is below 1500 grams.

Devices and methods for treating urinary incontinence are disclosed. In one embodiment, an implantable device uses non-biodegradable suture(s) positioned under or adjacent to the urethra. The sutures may be anchored by one of several methods including integration with mesh, tines, barbs, or an alternative anchoring system away from the urethra. A delivery system may comprise a hollow trocar with removable tip and handle. Methods for treating urinary incontinence using the devices are disclosed.

A urethral plug having a plug body, a lanyard and a stopper. The plug body having a leading end shaped to spread tissue at the urethral, a central portion; a trailing end tapering down from the central portion, and a sealing ring encircling the central portion. The plug body is shaped so that when positioned within the urethra the plug body is retained within the urethra, to restrict urine flow within the urethra past the plug body.

An intravaginal pessary device in an applicator is provided. The device has a top and a bottom, and a sidewall that extends between the top and the bottom. The sidewall, top and bottom form an outer periphery defining a total area of the device. The pessary device has a maximum diameter that is less than about 25 mm. The pessary device and applicator exhibit a maximum expulsion force that is below 1500 grams.

A device for implantation into a prostate-cavity of a patient having undergone a prostatectomy procedure is disclosed herein. The device includes a bag-body having an outer-shell and an inner-volume. In a preferred embodiment, the inner-volume is filled with a saline material. The device effectively fills the void after a prostatectomy procedure, helping patients quickly recover from the current side effects of surgery and preventing incontinence without having to endure intense therapy or invasive surgery.

A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, an adhesive carried on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a substance carried by at least one of the body and the adhesive and configured for controlling the odor of the general vaginal-urethral area of a female.

A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.

The disclosure describes a breast implant device product that mimics the natural pectoral fat of the breast and is characterized by an incomplete pyramid with isosceles triangular base and wedge-shaped edges and sloping faces that meet at acute angles with variable degree located medially, laterally, and on the top and a footprint characterized by a semicircular lower portion and an oval paraboloid upper portion and a center of gravity located closer to the footprint than to the profile, the said footprint is advantageously converging and moving towards the underlying surface as the chest wall with a method of manufacturing and a method of use of the said implant including a breast pyramid sizing system.